Literature DB >> 30381088

Cellular Toxicity of Mesoporous Silica Nanoparticle in SHSY5Y and BMMNCs Cell.

Shivendra Chauhan1, Geetha Manivasagam2, Pravir Kumar3, Rashmi K Ambasta4.   

Abstract

BACKGROUND: Mesoporous silica nanoparticles (MSNs) are emerging as one of the new and promising nanomaterials for biomedical applications, but enough investigation has not been done in the field of the biocompatibility of MSNs in vitro condition.
OBJECTIVE: The present study aims to investigate the toxicity of mesoporous silica nanoparticles in BM-MNCs and SHSY5Y Cell.
METHOD: The synthesis of MSN was performed and it was characterized for its size by SEM and XRD. The cellular toxicity of MSN was investigated by MTT assay as well as LDH assay in BMMNCs and SHSY5Y Cell.
RESULTS: In this article, cellular toxicity of mesoporous silica has been targeted keeping in view the size, toxicity, dose administered and in vitro toxicity. In the present study, mesoporous silica was synthesized and characterized for its size via SEM and XRD as 123.05 nM. The antibacterial test via disc diffusion assay was performed and no significant antimicrobial effect was found at low dose i. e less than 150 uM. The in vitro toxicity of MSN in bone marrow mononuclear cells and SHSY5Y cell was investigated in a time and dose-dependent manner. These results also confirmed no significant toxic effect at a low dose while at the higher doses, toxicity was observed.
CONCLUSION: Altogether, this article illuminates mesoporous silica as safe nanoparticle at low doses for drug delivery. The present finding will help researchers to develop and target MSN nanoparticlebased therapeutics for several applications in biological science. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  BM-MNCs; Cellular Toxicity; SEM; SHSY5Y; XRD; biomedical applications; mesoporous silica nanoparticle.

Mesh:

Substances:

Year:  2018        PMID: 30381088     DOI: 10.2174/2211738506666181031160108

Source DB:  PubMed          Journal:  Pharm Nanotechnol        ISSN: 2211-7385


  5 in total

Review 1.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

2.  Influence of Critical Parameters on Cytotoxicity Induced by Mesoporous Silica Nanoparticles.

Authors:  Amirsadra Ahmadi; Moses Sokunbi; Trisha Patel; Ming-Wei Chang; Zeeshan Ahmad; Neenu Singh
Journal:  Nanomaterials (Basel)       Date:  2022-06-11       Impact factor: 5.719

3.  Short-Term Oral Administration of Mesoporous Silica Nanoparticles Potentially Induced Colon Inflammation in Rats Through Alteration of Gut Microbiota.

Authors:  Yue Yu; Zhou Wang; Ran Wang; Jing Jin; Yi Zhun Zhu
Journal:  Int J Nanomedicine       Date:  2021-02-05

Review 4.  Application of Mesoporous Silica Nanoparticles in Cancer Therapy and Delivery of Repurposed Anthelmintics for Cancer Therapy.

Authors:  Maedeh Koohi Moftakhari Esfahani; Seyed Ebrahim Alavi; Peter J Cabot; Nazrul Islam; Emad L Izake
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

5.  Application of Mesoporous Silica Nanoparticle-Chitosan-Loaded BMP-2 in the Repair of Bone Defect in Chronic Osteomyelitis.

Authors:  Min Yi; Yu Nie; Chengyun Zhang; Bin Shen
Journal:  J Immunol Res       Date:  2022-07-31       Impact factor: 4.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.